Lv1
38 积分 2024-01-18 加入
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
12天前
已完结
Genetically modified CD19-targeting IL-15 secreting NK cells for the treatment of systemic lupus erythematosus
1个月前
已完结
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity
2个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
3个月前
已完结
Stable expression of large transgenes via the knock-in of an integrase-deficient lentivirus
5个月前
已完结
Multiangle Light Scattering as a Lentivirus Purification Process Analytical Technology
5个月前
已完结
OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours
5个月前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
5个月前
已完结
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases
6个月前
已完结
The U.S. Food and Drug Administration’s Perspective on Chimeric Antigen Receptor T-Cell Therapies for Autoimmune and Rheumatic Conditions
6个月前
已完结
皖公网安备34019202002308
